共 36 条
- [21] How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter-Defibrillator Programming Diffuse Into Clinical Practice? Translation Assessed in a National Cohort of Patients With Implantable Cardioverter-Defibrillators (ALTITUDE) [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (03):
- [22] Impact of COVID-19 lockdown in patients with implantable cardioverter and cardiac resynchronization therapy defibrillators: insights from daily remote monitoring transmissions [J]. Heart and Vessels, 2021, 36 : 1694 - 1700
- [24] Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (11):
- [28] Distribution and impact of age in patients with implantable cardioverter-defibrillators regarding early complications and 1-year clinical outcome: results from the German Device Registry [J]. Journal of Interventional Cardiac Electrophysiology, 2021, 62 : 83 - 93
- [30] Einsatz des tragbaren Kardioverter-Defibrillators nach kardiochirurgischen EingriffenPositionspapier der AG Herzrhythmusstörungen der Deutschen Gesellschaft für Thorax‑, Herz- und GefäßchirurgieUse of wearable cardioverter defibrillators after cardiac surgeryPosition paper of the working group on cardiac arrhythmias of the German Society for Thoracic and Cardiovascular Surgery [J]. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2018, 32 (4) : 286 - 299